Aurinia Pharmaceuticals Inc. (AUPH) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 77.7M | 77.11M | 73.47M | 70.01M | 62.47M | 59.87M | 67.77M | 57.19M | 50.3M | 45.09M | 54.52M | 41.49M |
| Revenue Growth % | 24.4% | 28.81% | 8.41% | 22.41% | 24.18% | 32.76% | 24.32% | 37.83% | 46.19% | 58.59% | -2.27% | 47.19% |
| Cost of Goods Sold | 6.5M | 8.47M | 8.5M | 7.12M | 8.57M | 5.55M | 6.04M | 8.91M | 7.75M | 5.39M | 6.77M | 1.56M |
| COGS % of Revenue | 8.37% | 10.99% | 11.58% | 10.16% | 13.73% | 9.27% | 8.91% | 15.58% | 15.41% | 11.96% | 12.42% | 3.77% |
| Gross Profit | 71.2M | 68.64M | 64.96M | 62.89M | 53.89M | 54.31M | 61.74M | 48.28M | 42.55M | 39.7M | 47.75M | 39.93M |
| Gross Margin % | 91.63% | 89.01% | 88.42% | 89.84% | 86.27% | 90.73% | 91.09% | 84.42% | 84.59% | 88.04% | 87.58% | 96.23% |
| Gross Profit Growth % | 32.12% | 26.38% | 5.23% | 30.26% | 26.65% | 36.81% | 29.3% | 20.92% | 25.19% | 46.64% | -10.47% | 50.16% |
| Operating Expenses | 29.78M | 35.4M | 35.22M | 42.81M | 32.04M | 55.98M | 49.99M | 49.8M | 53.25M | 69.37M | 64.01M | 56.1M |
| OpEx % of Revenue | 38.32% | 45.91% | 47.94% | 61.15% | 51.3% | 93.51% | 73.76% | 87.07% | 105.85% | 153.84% | 117.42% | 135.2% |
| Selling, General & Admin | 22.03M | 29.25M | 26.18M | 26.02M | 20.34M | 45.26M | 42.37M | 44.93M | 47.7M | 50.07M | 47.76M | 43.64M |
| SG&A % of Revenue | 28.35% | 37.94% | 35.64% | 37.16% | 32.56% | 75.6% | 62.51% | 78.57% | 94.82% | 111.04% | 87.61% | 105.17% |
| Research & Development | 7.47M | 10.89M | 8.44M | 7.43M | 5.74M | 8.11M | 3.05M | 4.08M | 5.55M | 10.23M | 13.61M | 12.65M |
| R&D % of Revenue | 9.61% | 14.13% | 11.48% | 10.62% | 9.19% | 13.54% | 4.5% | 7.13% | 11.04% | 22.68% | 24.96% | 30.49% |
| Other Operating Expenses | 279K | -1000K | 602K | 1000K | 1000K | 1000K | 1000K | 782K | 0 | 1000K | 1000K | -190K |
| Operating Income | 41.42M | 33.24M | 29.75M | 20.08M | 21.85M | -1.67M | 11.75M | -1.51M | -10.7M | -29.67M | -16.26M | -16.17M |
| Operating Margin % | 53.31% | 43.1% | 40.49% | 28.69% | 34.97% | -2.79% | 17.33% | -2.65% | -21.26% | -65.8% | -29.83% | -38.97% |
| Operating Income Growth % | 89.6% | 2091.55% | 153.19% | 1427.36% | 304.27% | 94.38% | 172.24% | 90.64% | 63.85% | -5.6% | -71.21% | 55.07% |
| EBITDA | 46.24M | 38.1M | 34.61M | 24.95M | 26.7M | 3.19M | 16.64M | 3.33M | -5.85M | -24.73M | -10.81M | -15.45M |
| EBITDA Margin % | 59.5% | 49.41% | 47.11% | 35.63% | 42.75% | 5.33% | 24.55% | 5.82% | -11.63% | -54.83% | -19.83% | -37.24% |
| EBITDA Growth % | 73.16% | 1093.33% | 107.98% | 649.16% | 556.62% | 112.91% | 253.97% | 121.55% | 79.74% | 11.32% | -24.37% | 55.85% |
| D&A (Non-Cash Add-back) | 4.82M | 4.86M | 4.87M | 4.86M | 4.86M | 4.86M | 4.89M | 4.84M | 4.85M | 4.95M | 5.46M | 719K |
| EBIT | 44.94M | 42.2M | 31.96M | 23.27M | 25.42M | 2.32M | 16.02M | 2.68M | -8.73M | -25.11M | -11.75M | -12.07M |
| Net Interest Income | 2.5M | -1.92M | 2.22M | 2.07M | 2.5M | 2.84M | 3.06M | 2.99M | 3.24M | 3.26M | 3.11M | 4.04M |
| Interest Income | 3.52M | 4.6M | 2.22M | 3.19M | 3.57M | 3.99M | 4.27M | 4.19M | 4.53M | 4.57M | 4.51M | 4.1M |
| Interest Expense | 1.01M | 6.51M | 0 | 1.12M | 1.07M | 1.15M | 1.21M | 1.2M | 1.28M | 1.31M | 1.4M | 65K |
| Other Income/Expense | 2.5M | 2.45M | 2.22M | 2.07M | 2.5M | 2.84M | 3.06M | 2.99M | 685K | 3.26M | 3.11M | 4.04M |
| Pretax Income | 43.92M | 35.69M | 31.96M | 22.16M | 24.35M | 1.17M | 14.81M | 1.48M | -10.01M | -26.42M | -13.15M | -12.13M |
| Pretax Margin % | 56.53% | 46.28% | 43.5% | 31.65% | 38.98% | 1.96% | 21.85% | 2.58% | -19.9% | -58.58% | -24.12% | -29.24% |
| Income Tax | 9.57M | -175.1M | 411K | 643K | 1M | -256K | 457K | 756K | 739K | 459K | 298K | -642K |
| Effective Tax Rate % | 21.79% | -490.62% | 1.29% | 2.9% | 4.13% | -21.82% | 3.09% | 51.15% | -7.38% | -1.74% | -2.27% | 5.29% |
| Net Income | 34.35M | 210.79M | 31.55M | 21.51M | 23.34M | 1.43M | 14.35M | 722K | -10.75M | -26.88M | -13.45M | -11.49M |
| Net Margin % | 44.21% | 273.35% | 42.95% | 30.73% | 37.37% | 2.39% | 21.17% | 1.26% | -21.37% | -59.6% | -24.67% | -27.7% |
| Net Income Growth % | 47.17% | 14651.15% | 119.87% | 2879.64% | 317.17% | 105.32% | 206.72% | 106.28% | 58.98% | -3.18% | -49.59% | 67.64% |
| Net Income (Continuing) | 34.35M | 210.79M | 31.55M | 21.51M | 23.34M | 1.43M | 14.35M | 722K | -10.75M | -26.88M | -13.45M | -11.49M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.25 | 1.53 | 0.23 | 0.15 | 0.16 | 0.01 | 0.10 | 0.01 | -0.07 | -0.19 | -0.09 | -0.08 |
| EPS Growth % | 56.25% | 15200% | 133.5% | 1400% | 314.48% | 105.26% | 204.68% | 112.5% | 58.56% | -5.56% | -48.42% | 68% |
| EPS (Basic) | 0.26 | 1.58 | 0.24 | 0.16 | 0.16 | 0.01 | 0.10 | 0.01 | -0.07 | -0.19 | -0.09 | -0.08 |
| Diluted Shares Outstanding | 137.64M | 138.7M | 136.01M | 143.2M | 138.92M | 147.68M | 145.65M | 144.11M | 144.01M | 143.62M | 142.85M | 142.78M |
| Basic Shares Outstanding | 132.38M | 134.37M | 137.18M | 138.92M | 138.92M | 142.18M | 143.05M | 143.33M | 144.01M | 143.62M | 142.85M | 142.78M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |